Author:
Rüegg Curzio,Yilmaz Aysim,Bieler Grégory,Bamat Jeannine,Chaubert Pascal,Lejeune Ferdy J.
Publisher
Springer Science and Business Media LLC
Subject
General Biochemistry, Genetics and Molecular Biology,General Medicine
Reference50 articles.
1. Carswell, E.A. et al. An endotoxin-induced serum factor that causes necrosis of tumors. Proc. Natl. Acad. Sci. USA 72, 3666–3670 (1975).
2. Liénard, D., Ewalenko, P., Delmotte, J., Renard, N. & Lejeune, F.J. High-dose recombinant tumor necrosis factor alpha in combination with interferon gamma and melphalan in isolation perfusion of the limbs for melanoma and sarcoma, J. Clin. Oncol. 10, 52–60 (1992).
3. Lejeune, F.J. High dose recombinant tumour necrosis factor (rTNF alpha) administered by isolation perfusion for advanced tumours of the limbs: a model for biochemotherapy of cancer, Eur. J. Cancer 6, 1009–1016 (1995).
4. Lienard, D. et al. Isolated perfusion of the limb with high-dose tumor necrosis factor-alpha (TNF-alpha), interferon gamma (IFN-γ) and melphalan for melanoma stage III. Results of a multi-centre pilot study. Melanoma Res. 4, Suppl. 1, 21–26 (1994).
5. Renard, N. et al. von Willenbrand Factor release and platelet aggregation in human melanoma after perfusion with TNFα. J. Pathol. 176, 279–287 (1995).
Cited by
405 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献